| Cell line name |
TTC-1318 |
| Accession |
CVCL_AQ33 |
| Resource Identification Initiative |
To cite this cell line use: TTC-1318 (RRID:CVCL_AQ33) |
| Disease |
Embryonal rhabdomyosarcoma (NCIt: C8971) Embryonal rhabdomyosarcoma (ORDO: Orphanet_99757) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Male |
| Category |
Cancer cell line |
| STR profile |
Source(s): COG
Markers:| Amelogenin | X,Y |
| CSF1PO | 10,11 |
| D2S1338 | 20,24 |
| D3S1358 | 15,17 |
| D5S818 | 11 |
| D7S820 | 9,12 |
| D8S1179 | 13,14 |
| D13S317 | 11,12 |
| D16S539 | 12,13 |
| D18S51 | 12,15 |
| D19S433 | 14,15 |
| D21S11 | 32.2 |
| FGA | 20,24.2 |
| TH01 | 9,9.3 |
| TPOX | 8,9 |
| vWA | 17,18 |
Run an STR similarity search on this cell line |
| Publications | PubMed=19887553; DOI=10.1158/1535-7163.MCT-09-0365; PMCID=PMC2783569 Kai-Ji Hu, Cathy Lee, De-Xin Qiu, Abbas Fotovati, Alastair Davies, Samah Abu-Ali, Daniel H. Wai, Elizabeth R. Lawlor, Timothy J. Triche, Catherine J. Pallen, Sandra E. Dunn; Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Mol. Cancer Ther. 8:3024-3035(2009) PubMed=23665679; DOI=10.1038/onc.2013.129 Elizabeth I. Sokolowski, Claire B. Turina, Ken Kikuchi, David M. Langenau, Charles Keller; Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. Oncogene 33:1877-1889(2014) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q54973232
|
| Entry history |
| Entry creation | 02-May-2016 |
| Last entry update | 21-Mar-2023 |
| Version number | 4 |
|---|